{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:02:53Z","timestamp":1781262173200,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.adro.2026.102031","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:32:23Z","timestamp":1774110743000},"page":"102031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric Correlates of Acute Toxicities for Moderate Hypofractionated Whole-Breast Irradiation: Implications for ASTRO Planning Guidelines"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-0052","authenticated-orcid":false,"given":"Vishruta A.","family":"Dumane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Runnels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaida","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Mazumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102031_bib0001","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102031_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"9","author":"Trialists\u2019 Group","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0003","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Trialists\u2019 Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102031_bib0004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2026.102031_bib0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.adro.2026.102031_bib0006","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0007","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: The St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0008","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2010.04.042","article-title":"Fractionation for whole breast irradiation: An American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"81","author":"Smith","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102031_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0011","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ijrobp.2012.01.093","article-title":"Hypofractionated whole-breast radiation therapy: does breast size matter?","volume":"84","author":"Hannan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102031_bib0012","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1200\/JCO.2013.49.7842","article-title":"Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis","volume":"31","author":"Mukesh","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.adro.2026.102031_bib0014","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ijrobp.2014.09.032","article-title":"Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials","volume":"90","author":"Jagsi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102031_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.breast.2023.04.006","article-title":"Hypofractionation: The standard for external beam breast irradiation","volume":"69","author":"Brunt","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.adro.2026.102031_bib0016","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.breast.2022.01.018","article-title":"Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials","volume":"62","author":"Marta","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.adro.2026.102031_bib0017","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103090","article-title":"The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review","volume":"156","author":"Marta","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.adro.2026.102031_bib0019","first-page":"118","article-title":"Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish Breast Cancer Group (DBCG) HYPO trial","volume":"28","author":"Thomsen","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.radonc.2016.08.021","article-title":"Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial","volume":"121","author":"Pignol","year":"2016","journal-title":"Radiother Oncol"},{"issue":"34","key":"10.1016\/j.adro.2026.102031_bib0021","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1200\/JCO.20.01703","article-title":"Toward improving patients' experiences of acute toxicity from breast radiotherapy: Insights from the analysis of patient-reported outcomes in a large multicenter cohort","volume":"38","author":"Jagsi","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0022","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamaoncol.2022.0114","article-title":"Identifying patients whose symptoms are underrecognized during treatment with breast radiotherapy","volume":"8","author":"Jagsi","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0023","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jamaoncol.2022.1479","article-title":"Effect of supine vs prone breast radiotherapy on acute toxic effects of the skin among women with large breast size: A randomized clinical trial","volume":"8","author":"Vesprini","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.08.024","article-title":"Hypofractionated whole-breast irradiation in large-breasted women\u2014Is there a dosimetric predictor for acute skin toxicities?","volume":"103","author":"Patel","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102031_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2407-13-230","article-title":"Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities","volume":"13","author":"Tortorelli","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2026.102031_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.meddos.2018.01.004","article-title":"Modifiable risk factors for acute skin toxicity in adjuvant breast radiotherapy: Dosimetric analysis and review of the literature","volume":"44","author":"Keenan","year":"2019","journal-title":"Med Dosim"},{"key":"10.1016\/j.adro.2026.102031_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.adro.2018.10.005","article-title":"The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients","volume":"4","author":"Butler-Xu","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.breast.2014.01.011","article-title":"Accelerated hypofractionated breast radiotherapy: FAQs (frequently asked questions) and facts","volume":"23","author":"Montero","year":"2014","journal-title":"Breast"},{"issue":"suppl 2","key":"10.1016\/j.adro.2026.102031_bib0029","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.breast.2015.07.025","article-title":"Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues","volume":"24","author":"Yarnold","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.adro.2026.102031_bib0030","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/S1470-2045(19)30078-6","article-title":"Moderately hypofractionated breast radiation therapy: Is more evidence needed?","volume":"20","author":"Marta","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102031_bib0031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijrobp.2011.05.074","article-title":"Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients","volume":"83","author":"Dorn","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102031_bib0032","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2020.02.018","article-title":"Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry","volume":"146","author":"Schmeel","year":"2020","journal-title":"Radiother Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:46:29Z","timestamp":1781261189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2452109426000382"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102031","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric Correlates of Acute Toxicities for Moderate Hypofractionated Whole-Breast Irradiation: Implications for ASTRO Planning Guidelines","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102031"}}